S100PBP
Basic information
Region (hg38): 1:32816767-32858875
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the S100PBP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 13 | |||||
Total | 0 | 0 | 33 | 7 | 8 |
Variants in S100PBP
This is a list of pathogenic ClinVar variants found in the S100PBP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-32816919-G-C | Likely benign (Nov 08, 2018) | |||
1-32817014-G-A | Benign (Aug 30, 2018) | |||
1-32817172-A-G | not specified • Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Oct 10, 2024) | ||
1-32817174-C-A | Charcot-Marie-Tooth disease dominant intermediate C • not specified | Benign (Feb 03, 2025) | ||
1-32817178-C-A | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Sep 06, 2023) | ||
1-32817178-C-T | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Feb 02, 2021) | ||
1-32817184-T-A | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (May 16, 2021) | ||
1-32817187-C-A | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 24, 2023) | ||
1-32817187-C-T | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 03, 2021) | ||
1-32817190-G-T | Inborn genetic diseases | Uncertain significance (Mar 31, 2023) | ||
1-32817191-C-A | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 24, 2023) | ||
1-32817193-G-A | not specified • Charcot-Marie-Tooth disease dominant intermediate C • Inborn genetic diseases | Benign/Likely benign (Jan 31, 2025) | ||
1-32817198-C-T | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jun 13, 2024) | ||
1-32817199-G-A | Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset | Likely pathogenic (-) | ||
1-32817200-G-A | Charcot-Marie-Tooth disease dominant intermediate C | Conflicting classifications of pathogenicity (Oct 13, 2024) | ||
1-32817201-G-T | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Dec 22, 2020) | ||
1-32817202-T-C | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Apr 06, 2023) | ||
1-32817203-G-A | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Dec 23, 2021) | ||
1-32817204-A-G | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Feb 14, 2023) | ||
1-32817205-T-A | Charcot-Marie-Tooth disease dominant intermediate C • Inborn genetic diseases • not specified | Conflicting classifications of pathogenicity (Mar 19, 2025) | ||
1-32817228-C-T | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Feb 07, 2024) | ||
1-32817236-G-GT | Uncertain significance (Mar 19, 2023) | |||
1-32817272-C-T | not specified | Likely benign (Jan 05, 2017) | ||
1-32817354-C-T | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jan 12, 2018) | ||
1-32817373-G-T | Charcot-Marie-Tooth disease dominant intermediate C | Benign (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
S100PBP | protein_coding | protein_coding | ENST00000373475 | 5 | 42109 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.945 | 0.0549 | 125726 | 0 | 10 | 125736 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0765 | 220 | 223 | 0.986 | 0.0000117 | 2672 |
Missense in Polyphen | 51 | 63.364 | 0.80487 | 847 | ||
Synonymous | -0.840 | 95 | 85.1 | 1.12 | 0.00000460 | 791 |
Loss of Function | 3.49 | 2 | 18.0 | 0.111 | 0.00000101 | 209 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000376 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000206 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.178
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.2
Haploinsufficiency Scores
- pHI
- 0.131
- hipred
- N
- hipred_score
- 0.273
- ghis
- 0.604
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.865
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- S100pbp
- Phenotype
Gene ontology
- Biological process
- Cellular component
- nucleus;cytosol;nuclear speck
- Molecular function
- calcium-dependent protein binding